EP1042674A4 - 148 human secreted proteins - Google Patents

148 human secreted proteins

Info

Publication number: EP1042674A4
Authority: EP; European Patent Office
Prior art keywords: secreted proteins; human secreted; human; proteins; secreted
Prior art date: 1997-10-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP98956146A

Other languages

German (de)

French (fr)

Other versions

EP1042674A1 (en

Inventor

Ping Feng

Craig A Rosen

Steven M Ruben

Jian Ni

Ying-Fei Wei

Daniel R Soppet

Paul A Moore

Hla Kayw

David W Lafleur

Henrik S Olsen

Laurie A Brewer

Yanggu Shi

Reinhard Ebner

Paul Young

John M Greene

Kimberly A Florence

Charles Florence

D Roxanne Duan

Fouad Janat

Gregory A Endress

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Human Genome Sciences Inc

Original Assignee

Human Genome Sciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-24

Filing date

1998-10-23

Publication date

2005-03-23

1998-10-23 Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc

2000-10-11 Publication of EP1042674A1 publication Critical patent/EP1042674A1/en

2005-03-23 Publication of EP1042674A4 publication Critical patent/EP1042674A4/en

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Neurosurgery (AREA)
Immunology (AREA)
Reproductive Health (AREA)
Hematology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Gynecology & Obstetrics (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Psychology (AREA)
Psychiatry (AREA)
Toxicology (AREA)
Zoology (AREA)
Hospice & Palliative Care (AREA)
Dermatology (AREA)
Oncology (AREA)
Transplantation (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pregnancy & Childbirth (AREA)
Emergency Medicine (AREA)

EP98956146A 1997-10-24 1998-10-23 148 human secreted proteins Withdrawn EP1042674A4 (en)

Applications Claiming Priority (35)

Application Number	Priority Date	Filing Date	Title
US6309997P	1997-10-24	1997-10-24
US6308997P	1997-10-24	1997-10-24
US6338797P	1997-10-24	1997-10-24
US6311197P	1997-10-24	1997-10-24
US6309897P	1997-10-24	1997-10-24
US6311097P	1997-10-24	1997-10-24
US6309297P	1997-10-24	1997-10-24
US6309197P	1997-10-24	1997-10-24
US6278497P	1997-10-24	1997-10-24
US6310197P	1997-10-24	1997-10-24
US6314897P	1997-10-24	1997-10-24
US6308897P	1997-10-24	1997-10-24
US6309097P	1997-10-24	1997-10-24
US6310997P	1997-10-24	1997-10-24
US6309797P	1997-10-24	1997-10-24
US6338697P	1997-10-24	1997-10-24
US6310097P	1997-10-24	1997-10-24
US62784P		1997-10-24
US63148P		1997-10-24
US63111P		1997-10-24
US63098P		1997-10-24
US63110P		1997-10-24
US63089P		1997-10-24
US63091P		1997-10-24
US63100P		1997-10-24
US63092P		1997-10-24
US63387P		1997-10-24
US63109P		1997-10-24
US63101P		1997-10-24
US63088P		1997-10-24
US63099P		1997-10-24
US63090P		1997-10-24
US63097P		1997-10-24
US63386P		1997-10-24
PCT/US1998/022376 WO1999022243A1 (en)	1997-10-24	1998-10-23	148 human secreted proteins

Publications (2)

Publication Number	Publication Date
EP1042674A1 EP1042674A1 (en)	2000-10-11
EP1042674A4 true EP1042674A4 (en)	2005-03-23

Family

ID=27586006

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP98956146A Withdrawn EP1042674A4 (en)	1997-10-24	1998-10-23	148 human secreted proteins

Country Status (5)

Country	Link
EP (1)	EP1042674A4 (en)
JP (1)	JP2003521865A (en)
AU (1)	AU1273499A (en)
CA (1)	CA2307320A1 (en)
WO (1)	WO1999022243A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002022638A1 (en) *	2000-09-12	2002-03-21	Human Genome Sciences, Inc.	22 human secreted proteins
US20020137890A1 (en) *	1997-03-31	2002-09-26	Genentech, Inc.	Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2000052151A2 (en) *	1999-03-05	2000-09-08	Incyte Pharmaceuticals, Inc.	Human secretory proteins
US6331413B1 (en)	1999-03-17	2001-12-18	Zymogenetics, Inc.	Secreted salivary ZSIG63 Polypeptide
AU4778600A (en) *	1999-05-20	2000-12-12	Takeda Chemical Industries Ltd.	Novel polypeptide
FR2796652B1 (en) *	1999-07-20	2003-03-21	Inst Nat Sante Rech Med	NUCLEIC ACIDS ENCODING PEPTIDES HAVING SORBIN BIOLOGICAL ACTIVITY
EP1233975A4 (en) *	1999-11-05	2004-07-07	Human Genome Sciences Inc	29 human secreted proteins
AU1922301A (en) *	1999-11-17	2001-05-30	Nyxis Neurotherapies, Inc.	Differential gene expression in cancer
WO2001079504A1 (en) *	2000-04-13	2001-10-25	Millennium Pharmaceuticals, Inc.	23155 NOVEL PROTEIN HUMAN 5-α REDUCTASES AND USES THEREFOR
AU2003294236A1 (en) *	2002-10-25	2004-05-25	Five Prime Therapeutics, Inc.	Methods of use for novel human polypeptides encoded by polynucleotides
TW201100090A (en) *	2009-04-01	2011-01-01	Oncotherapy Science Inc	C6orf167 peptides and vaccines containing the same

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995020398A1 (en) *	1994-01-27	1995-08-03	Human Genome Sciences, Inc.	Human growth hormone
WO1996017931A1 (en) *	1994-12-09	1996-06-13	Human Genome Sciences, Inc.	Human vascular ibp-like growth factor
WO1996039522A1 (en) *	1995-06-05	1996-12-12	Human Genome Sciences, Inc.	Human chemokine beta-11 and human chemokine alpha-1

1998
- 1998-10-23 CA CA002307320A patent/CA2307320A1/en not_active Abandoned
- 1998-10-23 EP EP98956146A patent/EP1042674A4/en not_active Withdrawn
- 1998-10-23 JP JP2000518285A patent/JP2003521865A/en not_active Withdrawn
- 1998-10-23 AU AU12734/99A patent/AU1273499A/en not_active Abandoned
- 1998-10-23 WO PCT/US1998/022376 patent/WO1999022243A1/en not_active Application Discontinuation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995020398A1 (en) *	1994-01-27	1995-08-03	Human Genome Sciences, Inc.	Human growth hormone
WO1996017931A1 (en) *	1994-12-09	1996-06-13	Human Genome Sciences, Inc.	Human vascular ibp-like growth factor
WO1996039522A1 (en) *	1995-06-05	1996-12-12	Human Genome Sciences, Inc.	Human chemokine beta-11 and human chemokine alpha-1

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
COLEMAN T A ET AL: "Production and purification of novel secreted human proteins", GENE: AN INTERNATIONAL JOURNAL ON GENES AND GENOMES, ELSEVIER SCIENCE PUBLISHERS, BARKING, GB, vol. 190, no. 1, 29 April 1997 (1997-04-29), pages 163 - 171, XP004064398, ISSN: 0378-1119 *
DATABASE EM_HUM [online] EMBL; 25 July 1997 (1997-07-25), MUZNY ET AL.: "Human Xp22 BAC CT-285I15 ..........", XP002302095, retrieved from EBI accession no. HSAC2366 Database accession no. AC002366 *
MARY P: "Le boom des chimiokines", BIOFUTUR. LE MENSUEL EUROPEEN DE BIOTECHNOLOGY, EDITIONS SCIENTIFIQUES ELSEVIER, PARIS, FR, vol. 1997, no. 165, March 1997 (1997-03-01), pages 32 - 37, XP004279638, ISSN: 0294-3506 *
See also references of WO9922243A1 *

Also Published As

Publication number	Publication date
WO1999022243A1 (en)	1999-05-06
EP1042674A1 (en)	2000-10-11
JP2003521865A (en)	2003-07-22
AU1273499A (en)	1999-05-17
CA2307320A1 (en)	1999-05-06

Publication	Publication Date	Title
EP1039801A4 (en)	2003-03-26	207 human secreted proteins
EP1000084A4 (en)	2003-03-26	123 human secreted proteins
EP1088071A4 (en)	2005-03-02	94 human secreted proteins
EP1100869A4 (en)	2005-04-27	98 human secreted proteins
EP1040117A4 (en)	2005-03-09	110 human secreted proteins
AU6552198A (en)	1998-09-29	28 human secreted proteins
EP1109821A4 (en)	2002-04-03	49 human secreted proteins
EP1078046A4 (en)	2005-05-11	97 human secreted proteins
EP1140970A4 (en)	2003-10-22	47 human secreted proteins
AU6952998A (en)	1998-10-30	20 human secreted proteins
EP1051426A4 (en)	2003-04-09	67 human secreted proteins
EP1064297A4 (en)	2003-05-07	95 human secreted proteins
EP1019091A4 (en)	2005-05-11	50 human secreted proteins
EP1005544A4 (en)	2004-07-14	70 human secreted proteins
AU8066998A (en)	1998-12-30	86 human secreted proteins
EP1044211A4 (en)	2005-03-23	36 human secreted proteins
EP1097199A4 (en)	2005-02-23	71 human secreted proteins
EP1115735A4 (en)	2002-04-17	31 human secreted proteins
EP1124850A4 (en)	2005-10-19	12 human secreted proteins
EP1032838A4 (en)	2003-01-29	125 human secreted proteins
EP1027430A4 (en)	2001-09-19	64 human secreted proteins
EP1009766A4 (en)	2003-04-09	19 human secreted proteins
EP1062236A4 (en)	2005-03-23	31 human secreted proteins
EP1159284A4 (en)	2003-10-29	33 human secreted proteins
EP1002132A4 (en)	2005-04-27	90 human secreted proteins

Legal Events

Date	Code	Title	Description
2000-08-25	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2000-10-11	17P	Request for examination filed	Effective date: 20000522
2000-10-11	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2005-03-23	A4	Supplementary search report drawn up and despatched	Effective date: 20050202
2005-08-17	17Q	First examination report despatched	Effective date: 20050628
2006-03-15	RIN1	Information on inventor provided before grant (corrected)	Inventor name: CARTER, KENNETH C. Inventor name: ENDRESS, GREGORY A. Inventor name: JANAT, FOUAD Inventor name: DUAN, D. ROXANNE Inventor name: FLORENCE, CHARLES Inventor name: FLORENCE, KIMBERLY A. Inventor name: GREENE, JOHN M. Inventor name: YOUNG, PAUL Inventor name: EBNER, REINHARD Inventor name: SHI, YANGGU Inventor name: BREWER, LAURIE A. Inventor name: OLSEN, HENRIK S. Inventor name: LAFLEUR, DAVID W. Inventor name: KAYW, HLA Inventor name: MOORE, PAUL A. Inventor name: SOPPET, DANIEL R. Inventor name: WEI, YING-FEI Inventor name: NI, JIAN Inventor name: RUBEN, STEVEN M. Inventor name: ROSEN, CRAIG A. Inventor name: FENG, PING
2006-03-31	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2006-05-17	18D	Application deemed to be withdrawn	Effective date: 20051109